Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.7207
+0.0307 (4.45%)
At close: Jul 16, 2025, 4:00 PM
0.7278
+0.0071 (0.99%)
After-hours: Jul 16, 2025, 7:59 PM EDT
Tenaya Therapeutics Stock Forecast
TNYA's stock price has decreased by -79.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts that cover Tenaya Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $8.6, which forecasts a 1093.28% increase in the stock price over the next year. The lowest target is $5 and the highest is $18.
Price Target: $8.6 (+1093.28%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 9, 2025.
Analyst Ratings
The average analyst rating for Tenaya Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 1 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 | Strong Buy | Maintains | $9 | +1,148.79% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +593.77% | Apr 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +593.77% | Mar 31, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $6 | Strong Buy | Maintains | $18 → $6 | +732.52% | Mar 13, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $15 → $5 | Buy | Maintains | $15 → $5 | +593.77% | Mar 12, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.29B
Revenue Next Year
n/a
EPS This Year
-0.81
from -1.31
EPS Next Year
-0.72
from -0.81
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 21.0M | 544.6M | ||
| Avg | n/a | 4.1M | 217.2M | ||
| Low | n/a | n/a | 49.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 13,249.0% | ||
| Avg | - | - | 5,222.5% | ||
| Low | - | - | 1,101.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.61 | -0.56 | 2.36 | ||
| Avg | -0.81 | -0.72 | 0.05 | ||
| Low | -1.05 | -1.18 | -0.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.